Integra LifeSciences Holdings Corporation (NASDAQ:IART) Q1 2022 Earnings Conference Call April 27, 2022 8:30 AM ET

Company Participants

Jan De Witte – President & Chief Executive Officer

Glenn Coleman – Chief Operating Officer

Carrie Anderson – Chief Financial Officer

Christopher Ward – Senior Director of Investor Relations

Conference Call Participants

Steven Lichtman – Oppenheimer & Company

Robbie Marcus – JPMorgan

Ryan Zimmerman – BTIG

Vik Chopra – Wells Fargo

Craig Bijou – Bank of America

David Turkaly – JMP Securities

Rich Newitter – Truist

Matt Miksic – Credit Suisse

Frank Camma – Jefferies

Jayson Bedford – Raymond James

Operator

Good day, ladies, and gentlemen. You are on hold for today's conference call. We're waiting arrival of additional participants and should be starting shortly. [Operator instructions]. Thank you for your patience and please continue to hold. Good day and welcome to the Integra LifeSciences First Quarter 2022 financial results. Today's conference is being recorded. At this time. I would like to turn the conference over to Mr. Christopher Ward, Senior Director Investor Relations. Please go ahead, sir.

Christopher Ward

Thank you, Cecelia. Good morning. And thank you for joining the Integral LifeSciences First Quarter 2022 Earnings Conference Call. Joining me on the call this morning are Jan De Witte, President and Chief Executive Officer, Glenn Coleman, Chief Operating Officer, and Carrie Anderson, Chief Financial Officer. Earlier today, we issued a press release announcing our first quarter 2022 financial results. The release and corresponding earnings presentation, which we will reference during the call, are available at integrallife.com under Investors, Events, and Presentations in the filed name first quarter 2022 earnings call presentation.

Before we begin, I would like to remind you that many of the statements made during this call may be considered forward-looking statements. Factors that could cause actual results to differ materially are discussed in the company's Exchange Act report filed with the SEC and in the release. Also, in our prepared remarks, we'll make reference to both reported and organic revenue growth. Organic revenue growth excludes the effects of foreign currency, acquisitions, including ACell for the first 19 days of the year, divestitures, as well as discontinued products.

Unless otherwise stated, all disaggregated franchise-level revenue growth rates are based on organic requirements. And lastly, our comments today will include certain non - GAAP financial measures. Reconciliations of any non - GAAP financial measures can be found in today's press release, which is an exhibit to Integra's current report on Form 8-K filed today with the SEC. And with that, I'll now turn the call over to Jan.